View Clinical Trial (Medical Research Study)
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
| City: |
|
Flint |
| State: |
|
Michigan |
| Zip Code: |
|
48503 |
| Conditions: |
|
Inhalation Injury - Pneumonitis - Pneumonia |
| Purpose: |
|
The investigators hypothesize that the scheduled use of bronchoscopy on a regular basis
after inhalation injury in burn patients will improve outcome by providing pulmonary
hygiene, decrease the incidence of pneumonia, and detect pneumonia earlier than standard
treatment without bronchoscopy.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. Any burned patient arriving intubated on mechanical ventilation OR requiring
mechanical ventilation within 48 hours of admission AND
2. > 18 years old AND
3. patient believed to be able to survive more than 48 hours after arrival (not likely
to be made DNR or comfort care) including:
- any methamphetamine explosion or
- any burn associated with fire (not chemical) of the face or blast injury to the
face or
- confined in a burning space for more than 10 minutes or
- any burn with carbonaceous material around the nose or mouth or
- any burn > 15% TBSA associated with fire (not chemical) or
- any burn associated with an explosion in a confined space.
Exclusion Criteria:
1. Likely to die within 48 hours based upon severity of injury.
2. Less than 18 years old.
3. Burned patient transferred to our facility already on mechanical ventilation for more
than 48 hours.
4. Patient already on antibiotics for another reason.
|
| NCT ID: |
|
NCT00997555 |
| Primary Contact: |
|
Principal Investigator
John A Carr, MD
Hurley Medical Center
John A Carr, MD
Phone: 810-424-4993 ext. 4993
Email: jcarr1@hurleymc.com
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Flint, Michigan 48503
United States
John A Carr, MD
Phone: 810-424-4993
Email: jcarr1@hurleymc.com
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|